BTL Exilis Ultra
BTL Exilis Ultra
Tighten & Sculpt
As we age, the things that keep our skin looking and feeling young naturally tend to take a downturn. The skin begins to loosen, showing signs of not only aging but sun damage, and the tone and texture change to accommodate that aging process. It doesn’t have to be that way, though. BTL Exilis seeks to reverse the signs of aging and address the skin’s laxity with its newest devices under BTL Exilis Ultra 360.
Using a non-invasive combination of radio frequency and ultrasound energy, BTL Exilis tightens loose skin, sculpts targeted areas, even reduces fat cells if you’re seeking subtle body sculpting and contouring. It’s truly a versatile device and can be used on both areas of the body that could use a lift or areas of the face suffering from sag and fine lines. Reduce the appearance of bags under the eyes, firm up a double chin, or tighten those love handles once and for all with BTL Exilis.
Take the next step and rejuvenate the skin you’re in with BTL Exilis in Orange County. Our experts at the Med Lounge are here to come up with a personalized treatment plan with you to get you the results you crave.
Benefits of BTL Exilis
Prevent and correct
Tighten loose skin
Reduce wrinkles
Even out skin tone and texture
Boost in collagen and elastin production
Deep skin improvement
Zero downtime
Confidence boost
Painless and effective
Extremely safe
Frequently Asked Questions
BTL Exilis is the only treatment that combines the power of radio frequency (RF) energy with ultrasound technology to target areas of the skin that could use tightening or a lift. That power combination works simultaneously, reducing fat cells, addressing skin laxity and boosting elastin and collagen production in targeted areas. The result is rejuvenated younger-looking skin.
BTL Exilis is very effective. The combination of RF energy and ultrasound penetrates both the superficial layer and deeper layers of the skin, leading to a boost in collagen and elastin production and longer-lasting improvements.
Effectiveness long-term can depend on the area and on the patient. While most will want touch-ups every six months, the ideal case scenario is improvements over time over the two years following your treatment. How you treat your body after your treatment could have a dramatic effect on results. That means a healthy diet and exercise to have long-lasting anti-aging effects on your newly toned and tightened skin.
BTL Exilis is ideal for those at or near their desired weight looking to subtly sculpt or tighten targeted areas of the face and body. Patients looking to reduce the appearance of fine lines and wrinkles will also benefit from the treatment’s skin tightening effects.
BTL Exilis is not for women who are pregnant, breastfeeding or may become pregnant. Patients with implanted devices should not receive BTL Exilis treatments. Share a complete medical history with your provider if you’re interested in a BTL Exilis skin tightening procedure, as they’ll be able to let you know whether you’re a good candidate BTL Exilis Ultra.
The cost of your BTL Exilis Ultra treatment will depend on how many treatments you schedule to reach your goals. Most patients benefit from 4 treatment sessions, spaced out anywhere between a week to 10 days.
Some patients see results from their BTL Exilis treatment after just one session, but most benefit from at least four sessions. Results last anywhere from six months to two years, with most patients returning for touchup procedures every 6-9 months to maintain desired outcomes.
Ideal outcomes can vary based on lifestyle habits. Following a healthy diet with regular exercise will keep your skin looking and feeling its best following treatment.
What to Expect With BTL Exilis
For the best results and to reduce the chance of any side effects after your treatment, our experts at the Med Lounge have a few tips around what to expect with BTL Exilis before and after your procedure.
PRE-TREATMENT
- Wear comfortable clothing on the day of your treatment. Your provider will need easy access to areas being targeted during your procedure.
- Leave the skin free of any lotions, makeup or serums the day of your treatment. Targeted areas should be free of hair, too.
- Remove any jewelry and put away electronic devices before starting your treatment.
- Hydration is important. Come to your appointment well-hydrated, and drink plenty of water in the days leading up to your treatment. Avoid beverages with a diuretic effect, like drinks containing caffeine and alcohol, a day or two ahead of your treatment.
- Talk to your provider about any cardiovascular conditions, implants or injuries you’ve experienced in the areas you’d like to target. Your provider will be able to tell you whether BTL Exilis is safe for you or whether you’re a better candidate for a different kind of treatment that will get you the results you’re looking for.
POST-TREATMENT
- You shouldn’t expect any downtime after treatment. Some light exercise is usually recommended after your BTL Exilis treatment. This stimulates your lymphatic system into action.
- You may experience some redness or tenderness in the targeted area in the days post-treatment. This is normal and will go away on its own within a day or two.
- You may also experience some sensitivity to heat post-treatment. Avoid scalding showers, saunas and too much sun exposure in the first few days after treatment. Protect your skin with sunscreen if you do head out in the sun shortly after your procedure.
- Keep well-hydrated in the days after treatment. Hydration boosts elasticity in the skin, improves tone, and helps you feel your best after your procedure.
- The recommended number of sessions for optimal results is four sessions. Schedule your sessions as advised by your provider at the end of your BTL Exilis appointment, and follow treatment instructions to the letter.
Botox Option #1
Everything You Need-
Most Popular Option
-
Minimum 10 Units
-
Competitive Pricing
Botox Option #2
Long Term Value-
For Long Term Goals
-
Minimum 30 Units
-
Best Overall Value
Botox Option #3
Yearly Unlimited Membership-
Unlimited Visits
-
Refer A Friend Rewards
-
Bonus Benefits
BOTOX® Cosmetic (onabotulinumtoxinA) Important Information
Indications
BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:
– Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
– Moderate to severe lateral canthal lines associated with orbicularis oculi activity
– Moderate to severe forehead lines associated with frontalis activity
IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING
WARNING: DISTANT SPREAD OF TOXIN EFFECT
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.
CONTRAINDICATIONS
BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.
WARNINGS AND PRECAUTIONS
Lack of Interchangeability Between Botulinum Toxin Products
The potency units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.
Spread of Toxin Effect
Please refer to Boxed Warning for Distant Spread of Toxin Effect.
No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported. Patients or caregivers should be advised to seek immediate medical care if swallowing, speech, or respiratory disorders occur.
Serious Adverse Reactions With Unapproved Use
Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.
Hypersensitivity Reactions
Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.
Cardiovascular System
There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.
Increased Risk of Clinically Significant Effects With Pre-existing Neuromuscular Disorders
Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).
Dysphagia and Breathing Difficulties
Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).
Pre-existing Conditions at the Injection Site
Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).
Dry Eye in Patients Treated With BOTOX® Cosmetic
There have been reports of dry eye associated with BOTOX® Cosmetic injection in or near the orbicularis oculi muscle. If symptoms of dry eye (eg, eye irritation, photophobia, or visual changes) persist, consider referring patients to an ophthalmologist.
Human Albumin and Transmission of Viral Diseases
This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.
ADVERSE REACTIONS
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for glabellar lines were eyelid ptosis (3%), facial pain (1%), facial paresis (1%), and muscular weakness (1%).
The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%), and eyelid ptosis (2%).
DRUG INTERACTIONS
Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.
The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by
administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.
Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.
USE IN SPECIFIC POPULATIONS
There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.
Please see BOTOX® Cosmetic full Prescribing Information including Boxed Warning and Medication Guide.
